Highland Capital Management Upped Its Boston Scientific (BSX) Holding by $325,318; As Thermo Fisher Scientific (TMO) Shares Declined, Congress Asset Management Company Lifted Holding by $709,796

Thermo Fisher Scientific Inc. (NYSE:TMO) Logo

Highland Capital Management Llc increased its stake in Boston Scientific Corp (BSX) by 40.42% based on its latest 2018Q3 regulatory filing with the SEC. Highland Capital Management Llc bought 8,561 shares as the company’s stock rose 0.86% while stock markets declined. The institutional investor held 29,739 shares of the medical and dental instruments company at the end of 2018Q3, valued at $1.15M, up from 21,178 at the end of the previous reported quarter. Highland Capital Management Llc who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $54.80 billion market cap company. The stock decreased 1.10% or $0.44 during the last trading session, reaching $39.6. About 6.24 million shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 44.37% since February 14, 2018 and is uptrending. It has outperformed by 44.37% the S&P500. Some Historical BSX News: 25/04/2018 – BSX SEES FY ADJ EPS $1.37 TO $1.41, SAW $1.35 TO $1.39; 21/03/2018 – BOSTON SCIENTIFIC – CO HAS EXISTING MINORITY INVESTMENT IN NXTHERA, EXPECTED TO RESULT IN UPFRONT PAYMENT OF ABOUT $240 MLN & MILESTONE PAYMENTS OF UP TO $85 MLN; 24/04/2018 – BOSTON SCIENTIFIC – ANNOUNCED ONE-YEAR DATA FROM INTREPID STUDY OF DEEP BRAIN STIMULATION FOR ADVANCED, LEVODOPA-RESPONSIVE PARKINSON’S DISEASE IN U.S; 16/04/2018 – Boston Scientific Announces Acquisition Of NVision Medical Corporation; 25/04/2018 – Boston Scientific 1Q EPS 21c; 14/05/2018 – Boston Scientific at AllianceBernstein Conference May 31; 16/04/2018 – BOSTON SCIENTIFIC-DEAL CONSISTS OF CASH PAYMENT OF $150 MLN, AND UP TO ADDITIONAL $125 MLN IN POTENTIAL CLINICAL & COMMERCIAL MILESTONES OVER 4 YEARS; 11/05/2018 – BSX EXPECTS 60 MINS WILL COVER INFO ALREADY PUBLICLY AVAILABLE; 16/04/2018 – BOSTON SCIENTIFIC PREVAILS IN EUROPEAN PATENT DISPUTE WITH; 16/04/2018 – Boston Scientific: Acquisition Launches Women’s Health Focus on Cancer

Congress Asset Management Company increased its stake in Thermo Fisher Scientific Inc. (TMO) by 1.15% based on its latest 2018Q3 regulatory filing with the SEC. Congress Asset Management Company bought 2,909 shares as the company’s stock declined 0.05% with the market. The institutional investor held 256,303 shares of the industrial machinery and components company at the end of 2018Q3, valued at $62.56 million, up from 253,394 at the end of the previous reported quarter. Congress Asset Management Company who had been investing in Thermo Fisher Scientific Inc. for a number of months, seems to be bullish on the $99.59B market cap company. The stock decreased 0.38% or $0.94 during the last trading session, reaching $247.39. About 1.01M shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 27.72% since February 14, 2018 and is uptrending. It has outperformed by 27.72% the S&P500. Some Historical TMO News: 19/03/2018 – Cubic Names Rhys Williams as New Vice President, Treasurer; 23/05/2018 – TMO ON TRACK TO EXCEED $80M TOTAL SYNERGY TARGET BY 2019:SLIDES; 25/04/2018 – Thermo Fisher 1Q Net $579M; 03/04/2018 – Rapid Mycoplasma Testing Method Now Accepted by Regulators for QA/QC and Lot Release; 15/03/2018 – Thermo Fisher Scientific Named IndustryWeek Best Plants Award Winner 2017; 15/03/2018 – Charité — Universitätsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence; 11/04/2018 – MUDRICK CAPITAL MANAGEMENT SAYS IT WOULD NOT SUPPORT ANY OVERTURE BY GLOBALSTAR TO SEEK ADDITIONAL FINANCING FROM CONTROLLING SHAREHOLDER THERMO COMPANIES; 10/04/2018 – Thermo Fisher Scientific Announces Its First Cloud-Enabled Biological Safety Cabinet; 24/05/2018 – Thermo Fisher Scientific Declares Quarterly Dividend; 12/04/2018 – Thermo Scientific Krios G3i Cryo-Electron Microscope Wins Gold Edison Award

Highland Capital Management Llc, which manages about $1.26 billion and $1.39 billion US Long portfolio, decreased its stake in Russell 1000 Growth Index (IWF) by 2,967 shares to 67,438 shares, valued at $10.52 million in 2018Q3, according to the filing. It also reduced its holding in Macys Inc (NYSE:M) by 64,525 shares in the quarter, leaving it with 184,203 shares, and cut its stake in Intel Corporation (NASDAQ:INTC).

Investors sentiment increased to 1.22 in Q3 2018. Its up 0.02, from 1.2 in 2018Q2. It is positive, as 37 investors sold BSX shares while 189 reduced holdings. 101 funds opened positions while 174 raised stakes. 1.20 billion shares or 0.24% less from 1.21 billion shares in 2018Q2 were reported. Ls Advsrs Ltd Liability Co accumulated 39,871 shares or 0.09% of the stock. Pub Employees Retirement Sys Of Ohio accumulated 946,625 shares. Richard Bernstein Advsr Llc holds 100,751 shares. 164,023 are held by Shell Asset Mgmt. Credit Suisse Ag holds 1.82 million shares. Earnest Prtnrs Lc accumulated 0% or 651 shares. Banced Corp has 14,325 shares for 0.94% of their portfolio. M&T Commercial Bank Corp holds 96,091 shares. First Mercantile Trust Co reported 6,100 shares or 0.05% of all its holdings. Mackenzie Fin Corporation owns 14,063 shares. 2.97 million were accumulated by Federated Investors Pa. Smith Salley And Assocs holds 0.05% in Boston Scientific Corporation (NYSE:BSX) or 8,697 shares. Moreover, Nj State Employees Deferred Compensation Plan has 0.26% invested in Boston Scientific Corporation (NYSE:BSX) for 40,000 shares. Moreover, Ibm Retirement Fund has 0.2% invested in Boston Scientific Corporation (NYSE:BSX). Point72 Asset Lp, a Connecticut-based fund reported 3.06M shares.

Among 34 analysts covering Boston Scientific Corporation (NYSE:BSX), 29 have Buy rating, 0 Sell and 5 Hold. Therefore 85% are positive. Boston Scientific Corporation had 112 analyst reports since July 27, 2015 according to SRatingsIntel. BMO Capital Markets maintained the stock with “Buy” rating in Tuesday, December 12 report. The rating was maintained by Stifel Nicolaus on Thursday, October 26 with “Buy”. Stifel Nicolaus maintained it with “Buy” rating and $25 target in Thursday, April 28 report. Jefferies maintained it with “Hold” rating and $28.0 target in Tuesday, September 5 report. SunTrust initiated Boston Scientific Corporation (NYSE:BSX) on Thursday, February 25 with “Buy” rating. SunTrust maintained Boston Scientific Corporation (NYSE:BSX) rating on Tuesday, October 31. SunTrust has “Buy” rating and $34.0 target. The rating was maintained by Jefferies with “Hold” on Tuesday, June 27. Raymond James downgraded Boston Scientific Corporation (NYSE:BSX) on Monday, October 5 to “Strong Buy” rating. The rating was reinitiated by Credit Suisse with “Outperform” on Monday, August 10. Needham maintained Boston Scientific Corporation (NYSE:BSX) rating on Wednesday, April 25. Needham has “Buy” rating and $3600 target.

Since August 15, 2018, it had 0 insider purchases, and 24 insider sales for $22.23 million activity. $368,079 worth of Boston Scientific Corporation (NYSE:BSX) was sold by Pierce David A. Another trade for 37,430 shares valued at $1.42M was made by Ballinger Kevin J. on Monday, September 24. On Monday, September 10 the insider Sorenson John Bradley sold $358,607. $1.77 million worth of Boston Scientific Corporation (NYSE:BSX) shares were sold by Fitzgerald Joseph Michael. Thepaut Eric Francis Yves also sold $562,019 worth of Boston Scientific Corporation (NYSE:BSX) on Thursday, November 29. Butcher Arthur C had sold 4,000 shares worth $154,000.

More notable recent Boston Scientific Corporation (NYSE:BSX) news were published by: 247Wallst.com which released: “Top Analyst Upgrades and Downgrades: Activision, Biogen, Deere, DocuSign, Ford, Freeport-McMoRan, GM, Lattice Semi, Qualys, Shopify, Under Armour and More – 24/7 Wall St.” on February 13, 2019, also Seekingalpha.com with their article: “Boston Scientific Channels Red Sox Winning Streak – Seeking Alpha” published on November 07, 2018, Investorplace.com published: “Can You Still Profit From Boston Scientific’s Tremendous Run? – Investorplace.com” on October 03, 2018. More interesting news about Boston Scientific Corporation (NYSE:BSX) were released by: Forbes.com and their article: “Boston Scientific’s Q4 Earnings And What Lies Ahead For The Company In 2019 – Forbes” published on February 11, 2019 as well as Seekingalpha.com‘s news article titled: “Boston Scientific to buy BTG for £3.3B – Seeking Alpha” with publication date: November 20, 2018.

Since October 1, 2018, it had 0 insider buys, and 5 selling transactions for $39.04 million activity. Another trade for 1,100 shares valued at $277,176 was sold by Jacks Tyler. 9,500 shares were sold by Williamson Stephen, worth $2.29 million. On Monday, October 1 the insider CASPER MARC N sold $31.07M.

Congress Asset Management Company, which manages about $7.47B and $7.73 billion US Long portfolio, decreased its stake in Texas Roadhouse Inc (NASDAQ:TXRH) by 26,658 shares to 1.54 million shares, valued at $106.40M in 2018Q3, according to the filing. It also reduced its holding in Dowdupont Inc by 10,642 shares in the quarter, leaving it with 180,308 shares, and cut its stake in V F Corporation (NYSE:VFC).

Investors sentiment decreased to 0.85 in Q3 2018. Its down 0.23, from 1.08 in 2018Q2. It dropped, as 41 investors sold TMO shares while 434 reduced holdings. 111 funds opened positions while 295 raised stakes. 333.46 million shares or 0.38% more from 332.19 million shares in 2018Q2 were reported. Raymond James Assoc holds 0.1% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO) for 273,341 shares. Robeco Institutional Asset Management Bv owns 122,652 shares for 0.13% of their portfolio. 36 were accumulated by Hanson Mcclain Inc. Trustmark Retail Bank Department invested in 10,070 shares or 0.17% of the stock. Cohen Lawrence B reported 1.6% stake. Cornerstone Advisors holds 0.39% or 22,000 shares in its portfolio. Ledyard Financial Bank holds 4,583 shares. Cibc Ww owns 11,566 shares for 0.01% of their portfolio. Coastline Tru owns 29,960 shares. Gam Holdg Ag holds 6,561 shares. Comerica reported 5,520 shares stake. Amica Retiree Med Trust invested 0.59% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Janney Montgomery Scott Limited Liability Corporation reported 114,122 shares. Investec Asset North America has invested 2.37% in Thermo Fisher Scientific Inc. (NYSE:TMO). Boyd Watterson Asset Management Ltd Liability Corporation Oh stated it has 2,041 shares.

Among 20 analysts covering Thermo Fisher Scientific (NYSE:TMO), 17 have Buy rating, 0 Sell and 3 Hold. Therefore 85% are positive. Thermo Fisher Scientific had 74 analyst reports since July 24, 2015 according to SRatingsIntel. Morgan Stanley maintained the stock with “Overweight” rating in Thursday, July 26 report. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Overweight” rating given on Monday, September 24 by Barclays Capital. The firm earned “Buy” rating on Wednesday, January 3 by Evercore. The company was maintained on Friday, May 27 by Mizuho. On Tuesday, October 6 the stock rating was initiated by Argus Research with “Buy”. The company was maintained on Thursday, February 1 by Barclays Capital. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Hold” rating given on Friday, April 29 by Jefferies. Jefferies maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Tuesday, June 6. Jefferies has “Hold” rating and $17500 target. BTIG Research reinitiated Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Friday, July 22. BTIG Research has “Buy” rating and $180 target. Jefferies maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Thursday, February 1. Jefferies has “Hold” rating and $230.0 target.

Thermo Fisher Scientific Inc. (NYSE:TMO) Institutional Positions Chart